Pfizer Inc. (PFE)
25.90
-0.14
(-0.52%)
USD |
NYSE |
Dec 08, 09:57
Pfizer Research and Development Expense (Quarterly): 2.492B for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 1.338B |
| Vertex Pharmaceuticals, Inc. | 977.70M |
| Viking Therapeutics, Inc. | 89.95M |
| Arvinas, Inc. | 64.30M |
| Moderna, Inc. | 749.00M |